Scotts Miracle-Gro Director Adds 133 Dividend Equivalent Rights to Holdings
Rhea-AI Filing Summary
Stephen L. Johnson, a director of The Scotts Miracle-Gro Company (SMG), reported an acquisition on 09/05/2025 of 133 dividend equivalent rights tied to DSU/RSU grants at an economic price of $63.04 each. The filing states each dividend equivalent right is the economic equivalent of one common share. Following the reported transaction, Mr. Johnson beneficially owned 789 common shares directly. The Form 4 was signed on behalf of Mr. Johnson by an attorney-in-fact on 09/09/2025.
Positive
- Acquisition of 133 dividend equivalent rights increases the reporting person's direct economic interest in SMG.
- Clear disclosure that dividend equivalent rights are economically equivalent to one common share each.
Negative
- None.
Insights
TL;DR Director acquired dividend equivalent rights from equity awards, modestly increasing direct economic exposure to SMG.
The transaction represents a routine settlement of equity-linked compensation rather than an open-market investment decision. The filing clarifies these are dividend equivalent rights tied to DSUs/RSUs and not new option grants. The number acquired (133) and the post-transaction direct holding (789 shares) are modest relative to large insider positions, indicating limited governance impact. Documentation appears complete with attorney-in-fact signature.
TL;DR This Form 4 reports a small acquisition of equity-equivalent rights at $63.04; impact on ownership and valuation is minimal.
The recorded price of $63.04 is presented as the economic equivalent per dividend right; the report does not show open-market purchases or sales. The net change increases direct beneficial ownership by 133 equivalent shares to 789 shares. For investors, this is a routine insider compensation-related transaction with no material change to control or capital structure disclosed in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights | 133 | $63.04 | $8K |
Footnotes (1)
- [object Object]